Raffa Wealth Management’s BeOne Medicines ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.46K Hold
4
– – ﹤0.01% 913
2026
Q2
$1.14K Buy
4
+2
+100% +$589 ﹤0.01% 979
2026
Q1
$594 Hold
2
– – ﹤0.01% 1045
2025
Q4
$608 Hold
2
– – ﹤0.01% 1041
2025
Q3
$681 Hold
2
– – ﹤0.01% 991
2025
Q2
$484 Sell
2
-5
-71% -$1.23K ﹤0.01% 1003
2025
Q1
$1.9K Hold
7
– – ﹤0.01% 644
2024
Q4
$1.29K Buy
7
+5
+250% +$1.02K ﹤0.01% 789
2024
Q3
$449 Hold
2
– – ﹤0.01% 1000
2024
Q2
$285 Hold
2
– – ﹤0.01% 1102
2024
Q1
$313 Hold
2
– – ﹤0.01% 1078
2023
Q4
$361 Hold
2
– – ﹤0.01% 1001
2023
Q3
$360 Hold
2
– – ﹤0.01% 992
2023
Q2
$357 Hold
2
– – ﹤0.01% 1001
2023
Q1
$431 Hold
2
– – ﹤0.01% 987
2022
Q4
$440 Hold
2
– – ﹤0.01% 975
2022
Q3
$270 Hold
2
– – ﹤0.01% 1108
2022
Q2
$324 Hold
2
– – ﹤0.01% 1075
2022
Q1
$377 Sell
2
-1
-33% -$213 ﹤0.01% 1082
2021
Q4
$813 Sell
3
-4
-57% -$1.35K ﹤0.01% 942
2021
Q3
$2.54K Hold
7
– – ﹤0.01% 552
2021
Q2
$2.4K Hold
7
– – ﹤0.01% 570
2021
Q1
$2.44K Buy
7
+2
+40% +$662 ﹤0.01% 584
2020
Q4
$1.29K Buy
5
+4
+400% +$1.1K ﹤0.01% 679
2020
Q3
$286 Buy
+1
New +$235 ﹤0.01% 858

Other funds holding ONC

Raffa Wealth Management's ONC Position: Q3 2026 in Review

Raffa Wealth Management held its BeOne Medicines (ONC) position steady in Q3 2026 at 4 shares worth $1.46K. The position accounts for ﹤0.01% of the portfolio, ranked #913.

Raffa Wealth Management first reported a position in ONC in Q3 2020 and has held it in 25 quarters since. The position peaked at $2.54K in Q3 2021. 325 funds tracked by Wall St. Rank hold ONC as of Q3 2026.

  • Raffa Wealth Management held 4 shares of BeOne Medicines worth $1.46K as of Q3 2026.
  • Raffa Wealth Management left its BeOne Medicines share count unchanged in Q3 2026.
  • BeOne Medicines made up ﹤0.01% of Raffa Wealth Management's portfolio in Q3 2026, its #913 holding.
  • Raffa Wealth Management first reported a position in BeOne Medicines in Q3 2020 and has held it in 25 quarters since.
  • Raffa Wealth Management's BeOne Medicines position peaked at $2.54K in Q3 2021.
  • 325 funds tracked by Wall St. Rank held BeOne Medicines as of Q3 2026.

Based on Raffa Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.